Free Trial

Amplify Treatments, Testing and Advancements ETF (GERM) News Today

Amplify Treatments, Testing and Advancements ETF logo
$19.16 0.00 (0.00%)
(As of 11/15/2024 ET)
Amplia Therapeutics Advances Cancer Drug Trial
Amplify ETFs to Liquidate Three ETFs
THNR Amplify Weight Loss Drug & Treatment ETF
ETFMG Treatments Testing and Advancements ETF
GERM ETFMG Treatments, Testing and Advancements ETF
Lactose Intolerance Treatment Market Growth by 2031
How to invest in the future of vaccines
SogoTrade Review
5 Must-Watch ETF Charts of Q2 Earnings
Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter.

The centerpiece of Trump’s crypto’s masterplan … (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Click here to find out more about what could be Trump and JD Vance’s favorite coin.

GERM Media Mentions By Week

GERM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GERM
News Sentiment

0.00

0.92

Average

News Sentiment

GERM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GERM Articles
This Week

0

0

GERM Articles
Average Week

Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEARCA:GERM) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners